Pure Global

A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients - Trial NCT06118229

Access comprehensive clinical trial information for NCT06118229 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital of Guangzhou Medical University and is currently Recruiting. The study focuses on Non Small Cell Lung Cancer. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06118229
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06118229
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
A Prospective Observational Study to the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients

Study Focus

Wearable smart devices and PROs

Observational

device

Sponsor & Location

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, China

Timeline & Enrollment

N/A

Mar 09, 2023

Jun 30, 2024

300 participants

Primary Outcome

Postoperative length of hospital stay

Summary

The trial was designed as a single-center non-interventional prospective observational study
 to explore the role and impact of wearable smart devices in perioperative NSCLC patients.

ICD-10 Classifications

Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung

Data Source

ClinicalTrials.gov

NCT06118229

Device Trial